Back
Janux Therapeutics Stock Predictions
Sponsored
JANX
Sponsored
32,481% Growth: Invest in the Smartphone Revolution @ $0.26/Share
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
JANX
Janux Therapeutics
Last Price:
68.59
Seasonality Move:
133.13%
7 Day Trial
ALL ACCESS PASS
$
7
Time-Waster to Money-Maker: Join Mode Mobile's $1T Revolution
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Janux Therapeutics Stock Forecast
- Over the next 52 weeks, Janux Therapeutics has on average historically risen by 98.6% based on the past 3 years of stock performance.
- Janux Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
-
Is Janux Therapeutics Stock Undervalued?
The current Janux Therapeutics [JANX] share price is $59.86. The Score for JANX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal. - JANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Janux Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Janux Therapeutics has on average historically risen by 98.6% based on the past 3 years of stock performance.
Janux Therapeutics Stock Rating
Sell
34
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics overpriced?
- Janux Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
Janux Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
januxrx.com
52-Week Data
52-Week High:
71.25
52-Week Low:
7.79
Prediction Charts
Market Cap:
3.14B
Price in USD:
59.86
Volume:
7.67M
Beta:
3.37
Technical Analysis
SMA50:
49.88
SMA100:
46.69
SMA200:
44.87
52-Wk Change:
562.17%
Stock Predictions
-
Is Janux Therapeutics stock public?
Yes, Janux Therapeutics is a publicly traded company. -
What is the Janux Therapeutics stock quote today?
The Janux Therapeutics stock price is 59.86 USD today. -
How to buy Janux Therapeutics stock online?
You can buy Janux Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Nov-13 | 52.92 | 52.03 | 53.71 | 51.93 |
Nov-14 | 51.39 | 51.10 | 52.87 | 50.55 |
Nov-15 | 50.41 | 48.76 | 51.09 | 48.34 |
Nov-18 | 48.70 | 48.12 | 49.14 | 47.04 |
Nov-19 | 47.75 | 49.01 | 49.74 | 47.50 |
Nov-20 | 48.34 | 48.96 | 49.34 | 47.61 |
Nov-21 | 49.04 | 46.50 | 49.78 | 45.95 |
Nov-22 | 46.50 | 50.31 | 50.63 | 46.02 |
Nov-25 | 51.08 | 48.82 | 52.39 | 48.40 |
Nov-26 | 48.82 | 48.00 | 49.74 | 47.70 |
Nov-27 | 48.10 | 46.39 | 49.69 | 46.30 |
Nov-29 | 46.13 | 45.21 | 46.93 | 45.18 |
Dec-2 | 45.02 | 40.18 | 45.90 | 40.02 |
Dec-3 | 67.17 | 59.86 | 71.25 | 59.30 |
Janux Therapeutics Earnings
Janux Therapeutics Earnings Report: Per Share Janux Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Janux Therapeutics Forecast Revenue Growth
Janux Therapeutics Stock Analysis: Historical quarterly revenues per share for Janux Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.91 per share.
* Janux Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.